Laparoscopy-assisted supracervical hysterectomy for ovarian cancer: Cervical recurrence

James Fanning, Joshua Kesterson, Andrea Benton, Sara Farag, Katherine Dodson-Ludlow

Research output: Contribution to journalArticle


Background and Objectives: The purpose of our study is to evaluate the incidence of cervical recurrence after laparoscopic supracervical hysterectomy for ovarian cancer debulking or staging. Methods: From a prospective surgical database, we identified 51 cases of laparoscopic supracervical hysterectomy for ovarian cancer debulking or staging. No cases were excluded. Results: From 2009 to 2012, 51 patients were identified. The median age was 62 years (range, 32–83 years), and the median body mass index was 29 kg/m2 (range, 16–41 kg/ m2). Medical comorbidities were present in 40 patients (78%), and 53% had prior abdominal surgery. The median operative time was 2 hours (range, 1–3.5 hours), and the median blood loss was 200 mL (range, 50–900 mL). The median length of stay was 1 day (range, 0–12 days). The stage was I in 12 patients, II in 6, and III/IV in 33. At amedian follow-up time of 1.7 years (range, 0.3–2.6 years), 20 patients (39%) had recurrence of cancer, with a median time of recurrence of 1.1 years (range, 0.3–2.3 years). All recurrences were in the abdomen or pelvis except for 1 axillary node recurrence and 1 recurrence in the distal vagina. There were no recurrences in the remaining cervical stump. No patient had a postoperative vaginal cuff infection. Among the 104 cycles of intraperitoneal chemotherapy, there was no vaginal leakage of intraperitoneal chemotherapy. Conclusion: Laparoscopic supracervical hysterectomy for ovarian cancer debulking or staging does not result in cervical recurrence.

Original languageEnglish (US)
Article numbere2014.00232
JournalJournal of the Society of Laparoendoscopic Surgeons
Issue number3
StatePublished - Jan 1 2014


All Science Journal Classification (ASJC) codes

  • Surgery

Cite this